Mölnlycke enters into a EUR 350 million credit facility agreement

On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility agreement. The facility has a tenor of five years with two one-year extension options and is provided by a syndicate of seven Nordic and international banks.

The facility is a refinancing of the existing and undrawn revolving credit facility from 2017 and will be used as a backup for general corporate purposes.

Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. Mölnlycke has around 8,700 employees and operates in more than 100 countries worldwide, with its headquarters in Gothenburg, Sweden.

Mölnlycke was advised by Mannheimer Swartling in the transaction.


This website uses cookies to perform certain functions and help you navigate the site efficiently. A cookie is a text file with a small amount of information that is stored on your device. We share some of the information we obtain through these cookies with third parties. We only use cookies that are necessary for the site to function correctly and they therefore cannot be turned off. For further information, see Information on the use of cookies.